Filing Details

Accession Number:
0001127602-16-061587
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-31 15:24:50
Reporting Period:
2016-08-29
Filing Date:
2016-08-31
Accepted Time:
2016-08-31 15:24:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524349 C Bryan Hanson Medtronic Plc
15 Hampshire Street
Mansfield MA 02048
Evp, President, Mitg No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-08-29 15,000 $29.52 168,192 No 4 M Direct
Ordinary Shares Disposition 2016-08-29 15,000 $87.00 153,192 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-08-29 15,000 $0.00 15,000 $29.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,802 2021-11-30 No 4 M Direct
Footnotes
  1. This exercise and sale occurred under a 10b5-1 plan.
  2. In the Merger, Covidien options outstanding as of closing were converted into options to buy shares of New Medtronic. This option to purchase 51,802 New Medtronic ordinary shares for $29.52 per share was received in the Merger and represents the conversion of 36,070 Covidien ordinary shares for $42.39 per share, which were partially vested at the time of the Merger. The conversion ratio and exercise price was calculated according to the terms of the Transaction Agreement, which does not allow for options on fractional shares of New Medtronic. Other than as to the number of underlying shares and the exercise price, this New Medtronic stock option has the same terms and conditions as the original Covidien stock option.